180 WEALTH ADVISORS, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1730817
FEDERAL WAY, WA
Position in VRTX
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$272,208
+$15,448 QoQ
Shares Held
548
-4.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#140
of 223 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 72.26277372262774.ToString("F0")%
Shared 0.ToString("F0")%
None 27.73722627737226.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026180 WEALTH ADVISORS, LLC holds $26,828,326 across 11 Biotechnology names. VRTX ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MNKD |
Mannkind Corp
|
4,959,351 | $21,126,835 | |
| 2 | MRNA |
Moderna, Inc.
|
35,750 | $2,503,572 | |
| 3 | INCY |
Incyte Corp
|
7,045 | $798,621 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
190,562 | $699,362 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
7,257 | $395,796 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
8,753 | $341,454 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
548 | $272,208 | |
| 8 | EXEL |
Exelixis, Inc.
|
4,266 | $232,113 |
All Filings in VRTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $272,208 | 548 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $256,760 | 575 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $260,682 | 575 | Shares | Sole | 2026-01-09 | |
| 2025-03-31 | $223,986 | 462 | Shares | Sole | 2025-04-09 | |
| 2024-09-30 | $424,152 | 912 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $448,565 | 957 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $407,977 | 976 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $277,905 | 683 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $237,506 | 683 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $239,650 | 681 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $246,384 | 782 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $200,702 | 695 | Shares | Sole | 2023-02-02 | |
| 2022-06-30 | $204,861 | 727 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $268,538 | 1,029 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $235,850 | 1,074 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $235,081 | 1,296 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $259,296 | 1,286 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $269,257 | 1,253 | Shares | Sole | 2021-05-25 | |
| 2020-12-31 | $293,061 | 1,240 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $287,358 | 1,056 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $200,023 | 689 | Shares | Sole | 2020-07-21 | |
| No filing history on record for this holder in this stock. | ||||||